Boston Scientific Corp (BSX)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 11,490,000 | 9,895,000 | 8,679,000 | 8,128,000 | 6,403,000 |
| Revenue | US$ in thousands | 16,747,000 | 14,240,000 | 12,682,000 | 11,888,000 | 9,913,000 |
| Gross profit margin | 68.61% | 69.49% | 68.44% | 68.37% | 64.59% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $11,490,000K ÷ $16,747,000K
= 68.61%
The gross profit margin of Boston Scientific Corp has shown positive trends over the past five years, increasing from 64.59% as of December 31, 2020, to 68.61% as of December 31, 2024. This signifies the company's ability to effectively manage its production costs in relation to its revenue generation. The steady improvement in the gross profit margin reflects the company's operational efficiency and potentially enhanced pricing strategy. However, a slight dip in the margin in 2023 followed by a rebound in 2024 suggests fluctuations that may warrant further investigation to ensure sustained profitability. Overall, Boston Scientific Corp has demonstrated a strong performance in maintaining and even increasing its gross profit margin over the years.
Peer comparison
Dec 31, 2024